Meihua Jin

11PUBLICATIONS
11CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 17, 2023
Inflammatory biomarkers predict outcomes of patients with radioactive iodine refractory thyroid cancer treated with sorafenib.

Meihua Jin, Mijin Kim, Min Ji Jeon

|Feb 24, 2023
Long-term follow-up result of antithyroid drug treatment of Graves' hyperthyroidism in a large cohort.

Meihua Jin, Ahreum Jang, Chae A Kim

|Apr 21, 2022
Lenvatinib Compared with Sorafenib as a First-Line Treatment for Radioactive Iodine-Refractory, Progressive, Differentiated Thyroid Carcinoma: Real-World Outcomes in a Multicenter Retrospective Cohort Study.

Mijin Kim, Meihua Jin, Min Ji Jeon

|Mar 11, 2022
Graves' disease diagnosed in remnant thyroid after lobectomy for thyroid cancer.

Meihua Jin, Ahreum Jang, Won Gu Kim

|Jan 31, 2022
Effect of TSH levels during active surveillance of PTMC according to age.

Hye In Kim, Meihua Jin, Nak Gyeong Ko

|Nov 27, 2021
Death-Associated Protein Kinase 1 Inhibits Progression of Thyroid Cancer by Regulating Stem Cell Markers.

Mi-Hyeon You, Woo Kyung Lee, Meihua Jin

Pageof 2

Frequent Collaborators

8 joint publications

Won Gu Kim

3 joint publications

Min Ji Jeon

2 joint publications

Yu-Mi Lee

2 joint publications

Woo Kyung Lee